TSXV CAD

ZERO CANDIDA TECHNOLOGIES INC (ZCT.V)

0.5600

0.0000

(0.00%)

At close: January 17 at 3:23:33 PM EST

Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar

Zero Candida Technologies, Inc. (TSXV: ZCT) (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, is pleased to announce that its shares are now successfully listed on the Frankfurt Stock Exchange (FSE) under the trading symbol "9L2". Their listing marks a significant milestone for the Company as it expands its global presence, now cross-listed on both the TSX Venture Exchange and the FSE, providing increased visibility and acce

PR Newswire 2 days ago

ZCT.V
0.00%
9L2.F
Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025

Zero Candida Technologies, Inc. (TSXV: ZCT), (FSE: 9L2) (the "Company" or "ZCT"), an Israeli FemTech medical device company focused on revolutionizing women's health, announces plans to complete preclinical studies for FDA submission by Q3 2025. In accordance with FDA requirements, the company is preparing to conduct a full preclinical study of its final human-use device in up to 24 additional sheep.

PR Newswire 12 days ago

ZCT.V
0.00%
9L2.F
Zero Candida Receives South African Patent for its ZC- 01 device

Zero Candida (the "Company" or "ZC") (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company has received a final patent from South Africa PCT patent PCT-IL 2023050243 in South Africa. In addition, the company is actively pursuing a global patent portfolio with applications filed worldwide including in the United States, Brazil, and Europe.

PR Newswire last month

ZCT.V
0.00%
Zero Candida Technologies Inc. (ZCT) Opens the Market

Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.Cannot view this video? Visit:https://www.youtube.com/watch?v=4Rj-qOUi3-sZero Candida Technologies, Inc. (ZCT), is a medical device c

Newsfile last month

ZCT.V
0.00%
Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)

Zero Candida (the "Company" or "ZCT"), (TSXV: ZCT) an Israeli FemTech medical device start-up, is pleased to announce full Transaction and Being Trading on November 25th on the TSX Venture Exchange (Canada) symbol : ZCT.

PR Newswire last month

ZCT.V
0.00%

Performance Overview

Return	ZCT.V	S&P/TSX Composite index
YTD	+5.66%	+1.82%
1-Year	-73.33%	+19.67%
3-Year	-73.33%	+17.37%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

ZERO CANDIDA TECHNOLOGIES INC (ZCT.V)

Zero Candida Announces Successful Listing on Frankfurt Stock Exchange and Details of Investor Webinar

Zero Candida Announces Plans to Complete Preclinical Studies for FDA Submission by Q3 2025

Zero Candida Receives South African Patent for its ZC- 01 device

Zero Candida Technologies Inc. (ZCT) Opens the Market

Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)

Performance Overview